Rehovot, Israel

Michael Mizhiritskii

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Michael Mizhiritskii: Innovator in Pharmaceutical Chemistry

Introduction

Michael Mizhiritskii is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and synthetic pathways. With a total of 10 patents to his name, Mizhiritskii's work has advanced the understanding and preparation of complex chemical structures.

Latest Patents

Mizhiritskii's latest patents include innovative methods for the large-scale preparation of pseudo-trisaccharide aminoglycosides. These patents detail synthetic pathways for creating pseudo-trisaccharide aminoglycoside compounds, as well as processes for stereoselectively preparing specific compounds while avoiding chromatographic separation of stereoisomers. Additionally, he has developed processes for preparing quinoline derivatives, such as laquinimod sodium, which are crucial in pharmaceutical applications.

Career Highlights

Throughout his career, Mizhiritskii has worked with notable companies in the pharmaceutical industry, including Mapi Pharma Ltd. and Eloxx Pharmaceuticals Ltd. His expertise in synthetic chemistry has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

Mizhiritskii has collaborated with esteemed colleagues, including Ehud Marom and Shai Rubnov. These partnerships have fostered innovation and have contributed to the successful development of his patented technologies.

Conclusion

Michael Mizhiritskii's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new therapeutic compounds and processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…